Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 60-65, April 2010

Dose–volume histogram and dose–surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma

Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan

Received 17 March 2009; received in revised form 24 August 2009; accepted 27 August 2009. published online 22 September 2009.

Abstract 

Background and purpose

To evaluate the usefulness of the dose–volume histogram (DVH) and dose–surface histogram (DSH) as clinically relevant and available parameters that helped to identify bone and soft tissue sarcoma patients at risk of developing late skin reactions, including ulceration, when treated with carbon ion radiotherapy.

Materials and methods

Thirty-five patients with bone and soft tissue sarcoma treated with carbon ion beams were studied. The clinical skin reactions were evaluated. Some pretreatment variables were compared with the grade of late skin reactions.

Results

Average DVH and DSH were established in accordance with the grading of the skin reactions. Prescribed dose, the difference in depths between the skin surface and the proximal extent of the tumor, and some DVH/DSH parameters were correlated with late skin reaction (grade 3) according to univariate analysis. Furthermore, the area irradiated with over 60GyE (S60>20cm2) on DSH was the most important factor by multivariate analysis.

Conclusions

The area irradiated with over 60GyE (S60>20cm2) on DSH was found to be a parameter for use as a predictor of late skin reactions.

Keywords: Dose–volume histogram, Dose–surface histogram, Carbon ion radiotherapy, Bone and soft tissue sarcoma, Skin reaction, Skin ulcer

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00493-9

doi:10.1016/j.radonc.2009.08.041

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 60-65, April 2010